StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 22 Apr 2024 07:56:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/Press+Releases/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html for the full story. http://www.streetinsider.com/PRNewswire/Par+Pharmaceutical+Issues+Voluntary+Nationwide+Recall+of+Seven+Lots+of+Treprostinil+Injection+Due+to+Potential+for+Silicone+Particulates+in+the+Product+Solution/23093933.html Mon, 22 Apr 2024 07:56:00 -0400 A.06822034 A.12554257 A.41185912 ENDPQ ENDPQ O.20026344 O.20975328 O.24069683 Endo International (ENDPQ) Launches Generic Version of DUEXIS http://www.streetinsider.com/Corporate+News/Endo+International+%28ENDPQ%29+Launches+Generic+Version+of+DUEXIS/22977030.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Endo+International+%28ENDPQ%29+Launches+Generic+Version+of+DUEXIS/22977030.html for the full story. http://www.streetinsider.com/Corporate+News/Endo+International+%28ENDPQ%29+Launches+Generic+Version+of+DUEXIS/22977030.html Tue, 26 Mar 2024 07:31:11 -0400 ENDPQ Endo International (ENDPQ) Launches Generic Version of DUEXIS http://www.streetinsider.com/FDA/Endo+International+%28ENDPQ%29+Launches+Generic+Version+of+DUEXIS/22977030.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/Endo+International+%28ENDPQ%29+Launches+Generic+Version+of+DUEXIS/22977030.html for the full story. http://www.streetinsider.com/FDA/Endo+International+%28ENDPQ%29+Launches+Generic+Version+of+DUEXIS/22977030.html Tue, 26 Mar 2024 07:31:11 -0400 ENDPQ Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html for the full story. http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Tue, 26 Mar 2024 07:30:00 -0400 A.02064631 A.09642568 A.12554257 A.50200193 ENDPQ ENDPQ O.20371933 O.24069683 O.36700628 Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html for the full story. http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Tue, 26 Mar 2024 07:30:00 -0400 A.02064631 A.09642568 A.12554257 A.50200193 ENDPQ ENDPQ O.20371933 O.24069683 O.36700628 Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html for the full story. http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Tue, 26 Mar 2024 07:30:00 -0400 A.02064631 A.09642568 A.12554257 A.50200193 ENDPQ ENDPQ O.20371933 O.24069683 O.36700628 Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html for the full story. http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Tue, 26 Mar 2024 07:30:00 -0400 A.02064631 A.09642568 A.12554257 A.50200193 ENDPQ ENDPQ O.20371933 O.24069683 O.36700628 Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html for the full story. http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Tue, 26 Mar 2024 07:30:00 -0400 A.02064631 A.09642568 A.12554257 A.50200193 ENDPQ ENDPQ O.20371933 O.24069683 O.36700628 Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html for the full story. http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Tue, 26 Mar 2024 07:30:00 -0400 A.02064631 A.09642568 A.12554257 A.50200193 ENDPQ ENDPQ O.20371933 O.24069683 O.36700628 Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html for the full story. http://www.streetinsider.com/Press+Releases/Endo+Launches+Ibuprofen-Famotidine+Tablets%2C+Generic+Version+of+DUEXIS%C2%AE/22977020.html Tue, 26 Mar 2024 07:30:00 -0400 A.02064631 A.09642568 A.12554257 A.50200193 ENDPQ ENDPQ O.20371933 O.24069683 O.36700628